Journal of Clinical Pediatrics ›› 2024, Vol. 42 ›› Issue (5): 439-444.doi: 10.12372/jcp.2024.23e0242
• Original Article • Previous Articles Next Articles
ZHOU Yiping, DOU Jiaying, CUI Yun, SHI Jingyi, SUN Ting, ZHANG Yucai()
Received:
2023-03-28
Online:
2024-05-15
Published:
2024-05-10
ZHOU Yiping, DOU Jiaying, CUI Yun, SHI Jingyi, SUN Ting, ZHANG Yucai. Clinical analysis of the first refractory status epilepticus in pediatric intensive care unit[J].Journal of Clinical Pediatrics, 2024, 42(5): 439-444.
"
项 目 | 总人数(n=80) | 死亡组(n=19) | 存活组(n=61) | 统计量 | P |
---|---|---|---|---|---|
性别(男/女) | 39/41 | 8/11 | 31/30 | χ2=0.44 | 0.507 |
年龄[M(P25~P75)]/月 | 38(12~80.75) | 48(19~97) | 30(10.50~78.50) | Z=1.01 | 0.311 |
BMI[M(P25~P75)]/kg·m-2 | 17.20(14.70~19.30) | 16.30(13.20~20.10) | 17.22(15.30~19.20) | Z=0.49 | 0.627 |
GCS评分[M(P25~P75)] | 7.50(6~11) | 4(3~7) | 8(6~11) | Z=4.27 | <0.001 |
临床诊断[n(%)] | |||||
重症脑炎 | 50(62.50) | 13(68.42) | 37(60.66) | χ2=0.37 | 0.542 |
免疫性脑炎 | 4(5.00) | 0 | 4(6.56) | 0.568 | |
癫痫综合征 | 9(11.25) | 0 | 9(14.75) | 0.106 | |
颅内出血或占位 | 7(8.75) | 3(15.79) | 4(6.56) | 0.348 | |
遗传代谢性脑病 | 4(5.00) | 1(5.26) | 3(4.92) | 1.000 | |
脓毒症脑病 | 3(3.75) | 0 | 3(4.92) | 1.000 | |
化脓性脑膜炎 | 3(3.75) | 2(10.53) | 1(1.64) | 0.139 | |
超难治性SE[n(%)] | 12(15.00) | 2(10.53) | 10(16.39) | 0.721 | |
<48 h使用丙泊酚[n(%)] | 4(5.00) | 1(5.26) | 3(4.92) | χ2=0.30 | 1.000 |
≥48 h使用丙泊酚[n(%)] | 8(10.00) | 1(5.26) | 7(11.48) | 0.672 | |
机械通气[n(%)] | 53(66.25) | 18(94.74) | 35(57.38) | Z=9.04 | 0.003 |
机械通气时间[M(P25~P75)]/h | 96(54~239) | 111.50 (27.50~265.80) | 96(60~234) | Z=0.18 | 0.858 |
惊厥持续时间[M(P25~P75)]/h | 19(2~46) | 3(2~40) | 21(2~56.50) | Z=1.49 | 0.136 |
影像学阳性/阴性 | 61/16 | 17/0 | 44/16 | 0.016 | |
住PICU日数[M(P25~P75)]/d | 8.50(5~17.80) | 5(3~11) | 10(6~19.50) | Z=2.58 | 0.010 |
"
项 目 | 结果(n=80) | 死亡组(n=19) | 存活组(n=61) |
---|---|---|---|
重症脑炎病原学[n(%)] | (n=50) | (n=13) | (n=37) |
肠道病毒 | 4 (8.00) | 1 (7.69) | 3 (8.11) |
流感病毒 | 5 (10.00) | 2 (15.38) | 3 (8.11) |
单纯疱疹病毒 | 3 (6.00) | 0 | 3 (8.11) |
支原体 | 1 (2.00) | 0 | 1 (2.70) |
隐球菌 | 1 (2.00) | 1 (7.69) | 0 |
病原不明 | 36 (72.00) | 9 (69.23) | 27 (72.97) |
MRI诊断[n(%)] | (n=77) | (n=16) | (n=61) |
颞叶/海马 | 12 (15.58) | 0 | 12 (19.67) |
基底节/丘脑 | 12 (15.58) | 0 | 12 (19.67) |
顶枕叶 | 5 (6.49) | 0 | 5 (8.20) |
双侧大脑皮质/广泛脑水肿 | 10 (12.99) | 9 (56.25) | 1 (1.64) |
小脑半球 | 2 (2.60) | 0 | 2 (3.28) |
脑室后角/脑室扩大 | 4 (5.19) | 0 | 4 (6.56) |
扣带回 | 1 (1.30) | 0 | 1 (1.64) |
颅内多发异常信号 | 5 (6.49) | 2 (12.50) | 3 (4.92) |
脑膜脑炎改变 | 4 (5.19) | 3 (18.75) | 1 (1.64) |
颅内占位和/或出血 | 6 (7.79) | 2 (12.50) | 4 (6.56) |
阴性 | 16 (20.78) | 0 | 16 (26.23) |
脑电图[n(%)] | (n=80) | (n=19) | (n=61) |
弥漫慢波 | 45 (56.25) | 14 (73.68) | 31 (50.82) |
广泛性周期性痫样放电 | 29 (36.25) | 3 (15.79) | 26 (42.62) |
高峰失律 | 3 (3.75) | 0 | 3 (4.92) |
爆发抑制 | 3 (3.75) | 2 (10.53) | 1 (1.64) |
抗癫痫药物[n(%)] | (n=80) | (n=19) | (n=61) |
3种 | 40 (50.00) | 13 (68.42) | 27 (44.26) |
4~5种 | 30 (37.50) | 6 (31.58) | 24 (39.34) |
>5种 | 10 (12.50) | 0 | 10 (16.39) |
超难治性SE | (n=12) | (n=2) | (n=10) |
48 h内使用丙泊酚[n(%)] | 4 (33.33) | 1 (50.00) | 3 (30.00) |
≥48 h使用丙泊酚[n(%)] | 8 (66.67) | 1 (50.00) | 7 (70.00) |
丙泊酚使用时间[M(P25~P75)]/h | 23 (20.5~445.75) | ||
爱可松[n(%)] | 8 (10%) | 0 | 8 (25.81) |
爱可松使用时间[M(P25~P75)]/h | 50.50 (14.75~558.75) | ||
免疫调节药物[n(%)] | |||
注射用甲基泼尼松龙琥珀酸钠 | 56 (70.00) | 13 (68.42) | 43 (70.49) |
静注人免疫球蛋白 | 56 (70.00) | 13 (68.42) | 43 (70.49) |
血浆置换 | 14 (17.50) | 0 | 14 (22.95) |
利妥昔单抗注射液 | 1 (1.25) | 0 | 1 (1.64) |
[1] |
Trinka E, Cock H, Hesdorffer D, et al. A definition and classification of status epilepticus--Report of the ILAE Task Force on Classification of Status Epilepticus[J]. Epilepsia, 2015, 56(10): 1515-1523.
doi: 10.1111/epi.13121 pmid: 26336950 |
[2] |
Kirmani BF, Au K, Ayari L, et al. Super-refractory status epilepticus: prognosis and recent advances in management[J]. Aging Dis, 2021, 12(4): 1097-1119.
doi: 10.14336/AD.2021.0302 |
[3] | Marawar R, Basha M, Mahulikar A, et al. Updates in refractory status epilepticus[J]. Crit Care Res Pract, 2018, 5(8): 9768949. |
[4] |
Johnson EL, Kaplan PW. Status epilepticus: definition, classification, pathophysiology, and epidemiology[J]. Semin Neurol, 2020, 40(6): 647-651.
doi: 10.1055/s-0040-1718722 pmid: 33176371 |
[5] |
Zimmern V, Korff C. Status epilepticus in children[J]. J Clin Neurophysiol, 2020, 37(5): 429-433.
doi: 10.1097/WNP.0000000000000657 pmid: 32890065 |
[6] |
Chin RFM. The outcomes of childhood convulsive status epilepticus[J]. Epilepsy Behav, 2019, 101(Pt B): 106286.
doi: 10.1016/j.yebeh.2019.04.039 |
[7] |
Pujar SS, Martinos MM, Cortina-Borja M, et al. Long-term prognosis after childhood convulsive status epilepticus: a prospective cohort study[J]. Lancet Child Adolesc Health, 2018, 2(2): 103-111.
doi: S2352-4642(17)30174-8 pmid: 30169233 |
[8] |
Martinos MM, Pujar S, Gillberg C, et al. Long-term behavioural outcomes after paediatric convulsive status epilepticus: a population-based cohort study[J]. Dev Med Child Neurol, 2018, 60(4): 409-416.
doi: 10.1111/dmcn.13636 pmid: 29226310 |
[9] |
Vasquez A, Farias-Moeller R, Tatum W. Pediatric refractory and super-refractory status epilepticus[J]. Seizure, 2019, 68: 62-71.
doi: S1059-1311(18)30025-6 pmid: 29941225 |
[10] |
Kantanen AM, Kälviäinen R, Parviainen I, et al. Predictors of hospital and one-year mortality in intensive care patients with refractory status epilepticus: a population-based study[J]. Crit Care, 2017, 21(1): 71.
doi: 10.1186/s13054-017-1661-x |
[11] | Ascoli M, Ferlazzo E, Gasparini S, et al. Epidemiology and outcomes of status epilepticus[J]. Int J Gen Med, 2021, 28(14): 2965-2973. |
[12] |
Vossler DG, Bainbridge JL, Boggs JG, et al. Treatment of refractory convulsive status epilepticus: a comprehensive review by the American Epilepsy Society Treatments Committee[J]. Epilepsy Curr, 2020, 20(5): 245-264.
doi: 10.1177/1535759720928269 |
[13] |
Neligan A, Noyce AJ, Gosavi TD, et al. Change in mortality of generalized convulsive status epilepticus in high-income countries over time: a systematic review and meta-analysis[J]. JAMA Neurol, 2019, 76(8): 897-905.
doi: 10.1001/jamaneurol.2019.1268 |
[14] | Lv RJ, Wang Q, Cui T, et al. Status epilepticus-related etiology, incidence and mortality: A meta-analysis[J]. Epilepsy Res, 2017, 10(136): 12-17. |
[15] |
Lattanzi S, Leitinger M, Rocchi C, et al. Unraveling the enigma of new-onset refractory status epilepticus: a systematic review of aetiologies[J]. Eur J Neurol, 2022, 29(2): 626-647.
doi: 10.1111/ene.v29.2 |
[16] |
Wickstrom R, Taraschenko O, Dilena R, et al. International consensus recommendations for management of new onset refractory status epilepticus including febrile infection‐related epilepsy syndrome: statements and supporting evidence[J]. Epilepsia, 2022, 63(11): 2840-2864.
doi: 10.1111/epi.v63.11 |
[17] |
Brugman J, Solomons RS, Lombard C, et al. Risk-stratification of children presenting to ambulatory paediatrics with first-onset seizures: should we order an urgent CT brain?[J]. J Trop Pediatr, 2020, 66(3): 299-314.
doi: 10.1093/tropej/fmz071 |
[18] | Al-Shami R, Khair AM, Elseid M, et al. Neuro-imaging evaluation after the first afebrile seizure in children: a retrospective observational study[J]. Seizure, 2016, 12(43): 26-31. |
[19] |
Glauser T, Shinnar S, Gloss D, et al. Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the Guideline Committee of the American Epilepsy Society[J]. Epilepsy Curr, 2016, 16(1): 48-61.
doi: 10.5698/1535-7597-16.1.48 pmid: 26900382 |
[20] |
Sidharth, Sharma S, Jain P, et al. Status Epilepticus in Pediatric patients Severity Score (STEPSS): a clinical score to predict the outcome of status epilepticus in children- a prospective cohort study[J]. Seizure, 2019, 71: 328-332.
doi: S1059-1311(19)30426-1 pmid: 31536850 |
[21] |
Kapoor D, Sidharth, Garg D, et al. Utility of the END-IT score to predict the outcome of childhood status epilepticus: a retrospective cohort study[J]. Ann Indian Acad Neurol, 2021, 24(3): 390-395.
doi: 10.4103/aian.AIAN_1319_20 |
[22] | Vasquez A, Farias-Moeller R, Sánchez-Fernández I, et al. Super-refractory status epilepticus in children: a retrospective cohort study[J]. Pediatr Crit Care Med, 2021, 22(12): e613-e625. |
[23] | Rebchuk AD, O'Neill ZR, Szefer EK, et al. Health utility weighting of the modified rankin scale: a systematic review and meta-analysis[J]. JAMA Netw Open, 2020, 3(4): e203767. |
[1] | MAO Meng, SHAO Jie, CHEN Jinjin, SHEN Lixiao. Interpretation of Catch-up growth in infants and young children with faltering growth: expert opinion to guide general clinicians [J]. Journal of Clinical Pediatrics, 2024, 42(5): 390-398. |
[2] | LI Dan, ZHANG Rui, LIU Feng, ZHAO Deyu. Correlation between overweight and obesity and lung function in children with asthma [J]. Journal of Clinical Pediatrics, 2024, 42(5): 429-433. |
[3] | LI Niu, LI Lei, CHEN Huiwen, WANG Jian, ZHANG Hao. Construction of the Shanghai children's rare disease registration database and summary of phased data [J]. Journal of Clinical Pediatrics, 2024, 42(2): 102-109. |
[4] | DING Xiaoyuan, ZHANG Yue, ZHANG Lishan, ZHANG Lei, YU Xiaodan. A cross-sectional study of hyperactive behavior comorbidity allergic diseases in pre-school children [J]. Journal of Clinical Pediatrics, 2023, 41(3): 215-218. |
[5] | WEN Jing, YU Yue, YANG Chunlan, LYU Jiayi, SONG Xinping, LI Yue, ZHANG Xiaoling, WANG Xiaodong, LIU Sixi. Changes of intestinal flora in children with β-thalassemia major before and after transplantation [J]. Journal of Clinical Pediatrics, 2023, 41(11): 833-838. |
[6] | ZHOU Jianguo. Etiologies of death and preventive strategies in extremely preterm infants [J]. Journal of Clinical Pediatrics, 2023, 41(10): 654-657. |
[7] | DONG Xiaoyan, MENG Chaoyue. Clinical consideration of viral pneumonia in children [J]. Journal of Clinical Pediatrics, 2022, 40(8): 561-565. |
[8] | WANG Lili, WU Haiying, XIE Rongrong, WANG Fengyun, CHEN Ting, CHEN Xiuli, SUN Hui, WANG Xiaoyan, ZHANG Dandan, CHEN Linqi. Analysis of genetic test results in 186 cases with short stature [J]. Journal of Clinical Pediatrics, 2022, 40(5): 349-354. |
[9] | SHI Xiuyu, HU Linyan, HAN Fang, ZOU Liping. Precision treatment in pediatric epilepsy [J]. Journal of Clinical Pediatrics, 2022, 40(3): 170-176. |
[10] | WANG Ying, LU Lina. Application of nutrition screening and assessment tools for hospitalized children [J]. Journal of Clinical Pediatrics, 2022, 40(11): 801-806. |
[11] | ZHU Jing. Research progress in human milk active ingredient-osteopontin [J]. Journal of Clinical Pediatrics, 2021, 39(4): 313-. |
[12] | HUANG Hui, DAI Xiaomei, WANG Sanfeng, et al. Correlation of subclinical acute kidney injury with adverse outcomes in critically ill neonates [J]. Journal of Clinical Pediatrics, 2021, 39(12): 881-. |
[13] | ZHOU Zhuying, WU Jing, ZHANG Zhijie, et al. Progress in diagnosis and treatment of epilepsia partialis continua in children [J]. Journal of Clinical Pediatrics, 2021, 39(10): 788-. |
[14] | ZHANG Qin, MIAO Hongjun. The diagnosis and management of hypertriglyceridemic pancreatitis in children [J]. Journal of Clinical Pediatrics, 2021, 39(10): 797-. |
[15] | JIANG Tao, LI Shuangjie, OUYANG Wenxian, et al. Etiological analysis of inherited metabolic liver disease in 330 children [J]. Journal of Clinical Pediatrics, 2021, 39(1): 6-. |
|